Tharimmune (THAR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

Tharimmune released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.9694

04:00

Tharimmune released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -0.3367

04:00

Aug20

Tharimmune Announces Positive Pharmacokinetic Modeling Results for TH104

12:01

Aug15

Tharimmune released FY2025 Semi-Annual earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -1.613

03:00

Tharimmune released FY2025 Q2 earnings on August 14 (EST) with actual revenue of USD 0 and EPS of USD -0.6447

03:00

Aug4

Tharimmune Launches First-In-Human Clinical Trial of Oral Antibody TH023

12:01

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.102 M, EPS -0.3367

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.855 M, EPS -0.6447

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -2.542 M, EPS -0.9879

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More